Mean blood cadmium (B-Cd) concentrations are two-to threefold higher in smokers than in nonsmokers. The basis for this phenomenon is not well understood. We conducted a detailed, multifaceted study of cadmium exposure in smokers. Groups were older smokers (62 ± 4 years, n = 25, 20% male) and nonsmokers (62 ± 3 years, n = 16, 31% male). Each subject's cigarettes were machine smoked, generating individually paired measures of inhaled cadmium (I-Cd) versus B-Cd; I-Cd and B-Cd were each evaluated three times, at monthly intervals. Urine cadmium (U-Cd) was analyzed for comparison. In four smokers, a duplicate-diet study was conducted, along with a kinetic study of plasma cadmium versus B-Cd. Female smokers had a mean B-Cd of 1.21 ng Cd/ml, with a nearly 10-fold range (0.29−2.74 ng Cd/ ml); nonsmokers had a lower mean B-Cd, 0.35 ng Cd/ml (p < 0.05), and narrower range (0.20-0.61 ng Cd/ml). Means and ranges for males were similar. Estimates of cadmium amounts inhaled daily for our subjects smoking ≥ 20 cigarettes/day were far less than the 15 µg Cd reported to be ingested daily via diet. This I-Cd amount was too low to alone explain the 3.5-fold elevation of B-Cd in our smokers, even assuming greater cadmium absorption via lungs than gastrointestinal tract; cadmium accumulated in smokers' lungs may provide the added cadmium. Finally, B-Cd appeared to be linearly related to I-Cd values in 75% of smokers, whereas 25% had far higher B-Cd, implying a possible heterogeneity among smokers regarding circulating cadmium concentrations and potentially cadmium toxicity.
). Patients with itai-itai disease in Japan, e.g., suffered extreme bone loss and kidney disease after consuming rice that was highly contaminated with cadmium (Nogawa, 1981; Takeuchi, 1978) .
More recently, urine cadmium (U-Cd) concentrations in humans have been directly correlated with increases not only in kidney dysfunction and osteoporosis-related fractures but also in cancer, cardiovascular effects, diabetes, and mortality among persons in the United States, Sweden, and Belgium, who were environmentally exposed to low levels of cadmium (Järup and Akesson, 2009 ). Cadmium has, thus, become the focus of many new studies regarding multiple potential health effects of this metal, as recently reviewed in detail by Satarug et al. (2010) . Of particular concern is the fact that the blood and urine concentrations of cadmium in the human studies are in range of those shown to adversely affect experimental animals (Bhattacharyya, 2009; Brzóska and Moniuszko-Jakoniuk, 2004; Engström et al., 2011; Gallagher et al., 2008; Järup and Akesson, 2009; Suwazono et al., 2010a,b; Wu et al., 2010) . Results in humans may, therefore, reflect true cause-and-effect relationships at much lower levels of cadmium exposure than previously recognized.
Cigarette smoking is a major source of cadmium exposure among persons who are environmentally exposed. Mean blood cadmium (B-Cd) concentrations have been shown to be higher in smokers than in nonsmokers by as much as two-to threefold (Batariova et al. 2006; El-Agha and Gökmen, 2002; Elinder et al., 1983) . Correspondingly, reductions in smoking rate and in environmental exposures to cigarette smoke in the United States appear to contribute to a decline in urinary cadmium levels from 1988 to 2008 (Tellez-Plaza et al., 2012) . Regarding toxic responses to cigarette smoke cadmium, Wills et al. (2009) have shown that the increased incidence of age-related macular degeneration that occurs among smokers appears to be related to their cadmium exposure. With respect to the kidney, cigarette toxicological sciences 130(1), 191-204 (2012) doi:10.1093/toxsci/kfs226 Advance Access publication July 24, 2012 smoking greatly increases the risk of having U-Cd concentrations above levels associated with increased microproteinuria and reduced glomerular filtration rate (Mortensen et al., 2011) . Thus, smoking is considered a significant risk factor for cadmium toxicity in the general population.
Apart from smoking, food is the most significant environmental source of cadmium to humans, with grains and leafy vegetables providing the largest fraction of daily intake among nonsmokers (Amzal et al., 2009; WHO/IPCS, 1992) . The gastrointestinal (GI) tract of humans absorbs 5-10% of cadmium ingested in food (Flanagan et al., 1978; Vanderpool and Reeves, 2001 ). This food pathway can be amplified by a number of factors, including marginal intakes of iron, calcium, zinc, or protein among women (Akesson et al., 2002; Flanagan et al., 1978; Satarug et al., 2004) . In comparison, cadmium absorption by the lungs in humans, although less well investigated, is reported at 30-50% of inhaled cadmium (I-Cd) (Järup and Akesson, 2009; Nordberg and Kjellstrom, 1979; Satarug et al., 2004) . Our hypothesis at the start of this study was that the much higher absorption of inhaled than ingested cadmium in humans would account for the elevated B-Cd concentrations in smokers.
In blood, the vast majority of cadmium circulates bound to red blood cells, with a very small fraction present in plasma (~1%) (Nordberg, 1984) . Cadmium concentrations in whole blood are expected to be relatively stable under continuous exposure conditions, reflective of cadmium's 2-to 3-month half-life in blood (Järup et al., 1983; Welinder et al., 1977) . Cadmium in plasma, bound mainly to albumin and metallothionein (MT), is rapidly taken up by the liver and kidneys of mice (Nordberg, 1984) . Few investigators have analyzed the plasma compartment in humans because of its very low cadmium concentrations (Murphy et al., 2007) . We used our sensitive cadmium assay to fill this gap by determining plasma cadmium (P-Cd) concentrations while a cigarette was smoked and shortly thereafter to test the extent to which this compartment might reflect recent exposures.
Estimating amounts of toxins that smokers inhale via mainstream cigarette smoke is a complex undertaking. The U.S. Federal Trade Commission (FTC) adopted standardized smoking machine regimens to measure tar and nicotine yields of cigarette smoke in the 1960s and carbon monoxide in 1981 (Federal Trade Commission, 1967) . The International Organization for Standardization (ISO) adopted methods that were applied in Europe and many other countries. These two regimens (ISO/ FTC) have the same puff volume, puff duration, puff interval, and vent blocking (0%); they differ in duration for conditioning cigarettes to a humidified environment (Counts et al., 2005; Torrence et al., 2002) . In our study, we applied FTC conditions to smoke cigarettes, with an increase in puff frequency from the FTC value of one puff per minute to three puffs per minute because the latter value was closer to that of our smokers and has been reported to better reflect smokers in general (June et al., 2011) .
Since the 1980s, investigators have come to understand that measurements made using the ISO/FTC protocol do not quantify the actual delivery of toxins to the smoker because individual smokers smoke with a variety of puff profiles that differ from those used in the standard smoking machine regimens. With a better understanding of modern cigarette designs and the concept of compensatory smoking of the low-yield cigarettes, the limitations of the ISO/FTC measurements have become more evident, even for comparisons of smoker exposures between brands of cigarettes (Djordevic et al., 2000; Hammond et al., 2005 Hammond et al., , 2006 Hammond et al., , 2007 Jarvis et al., 2001; NIH/ NCI, 1996) . In our study, we have addressed these limitations by comparing our I-Cd values to those expected if we had used more intense smoking regimens (Counts et al., 2005) or had been able to apply the actual smoking parameters of our individual smokers (Hammond et al., 2005 (Hammond et al., , 2006 .
Comprehensive studies have been conducted in humans that focus on the relationship between dietary cadmium intake versus U-Cd concentration as it reflects the accumulating body burden of cadmium (Amzal et al., 2009; Olsson et al., 2002; Reeves and Vanderpool, 1997) . The information available on cadmium inhaled by individuals who smoke cigarettes is far less extensive (Galazyn-Sidorczuk et al., 2008; Ikeda et al., 2005; Nordberg and Kjellstrom, 1979) . This report aims to fill that gap with results of an in-depth study of cadmium inhaled in mainstream smoke (external measure of cadmium intake due to smoking) and its effects on cadmium concentrations in whole blood, urine, and the blood plasma compartment (systemic measures of cadmium exposure). Subjects are postmenopausal women and a smaller set of age-matched men, with each subject sampled three times on a monthly basis. Individual values of I-Cd were estimated using a smoking machine to smoke cigarettes obtained from each subject. The results reported here provide a first look at individually paired values for I-Cd, B-Cd, P-Cd, and U-Cd. The results indicate that B-Cd in most subjects directly increased with I-Cd and U-Cd. However, ~25% of smokers appeared to develop higher smoking-related elevations in B-Cd concentration, potentially putting this subset at increased risk of cadmium's toxic effects.
MATERIALS AND METHODS
General study protocol. This study of cadmium exposure in postmenopausal women and age-matched men constituted Part 1 of a study of 41 Ca release from bone; group sizes were powered according to the 41 Ca study in females. Subjects were 20 female smokers and 11 female nonsmokers, all at least 5 years postmenopausal; a smaller group of male smokers and nonsmokers was included (Table 1) . Subjects were recruited from the suburban area around Argonne National Laboratory in Lemont, IL; they were identified through communication with retirement communities and via newspaper advertisement. For both genders, smoker and nonsmoker groups matched one another with respect to age, body weight, and body mass index; female smokers did not differ from nonsmokers in years since final menses (Table 1) . None of the subjects had been occupationally exposed to cadmium.
Cadmium exposure parameters were evaluated at three time points over 8 weeks. The focus was primarily on B-Cd concentrations to evaluate on-going exposure of internal organs to cadmium via the circulation. U-Cd was also analyzed to include an evaluation of cumulative cadmium exposure (Amzal et al., 2009) and to allow comparisons with U-Cd values published by others. Blood, urine, and cigarettes were collected from each subject at 0 time (M1) and at 1 and 2 months later (M2 and M3). Subjects ate lunch at noon on each sampling day and then refrained from eating for 3-4 h, after which blood and urine samples were collected (at 3:00 p.m.-4:00 p.m.). This approach gave uniformity to sampling time of day and aimed to minimize acute effects of dietary cadmium on B-Cd, in that cadmium concentrations have been shown to rise in internal organs as soon as 1 h after cadmium enters the stomach (Jonah and Bhattacharyya, 1989) . For smokers, cigarettes were collected from the pack they were using on that sampling day, and their smoking status was confirmed using ACCUTEST NicAlert test strips. Numbers of cigarettes smoked per day were obtained on two separate occasions: start-of-study questionnaire and daily diary of cigarettes smoked, taken 1 year later. The fact that the two values were well correlated (r = 0.85) gave us confidence in the subjects' recorded values. In addition, the questionnaire values were on average 20% higher than the daily diary values, indicating that the subjects did not try to minimize the daily smoking habits that they recorded in the start-of-study questionnaire. Because the study focused on B-Cd as it might reflect recent exposure, information on lifetime exposure to cigarette smoke (e.g., pack-years) was not obtained.
The specific gravity of each urine sample was recorded (Atago, PAL-10S digital refractometer) to allow urine concentration values to be adjusted for dilution effects between samples (Suwazono et al., 2005) . One-milliliter aliquots of whole blood and urine were stored at −20°C until analysis.
All tubes and collection containers were acid washed. The needles, blood vacutainer tubes, urine collection containers, and sample storage tubes were tested to document that they did not contribute significantly to the cadmium in our samples. Detailed instructions were given to the study participants on how to collect urine samples without cadmium contamination from hands, etc.-especially important for smokers. Highest purity water (18 MOhm) and nitric and sulfuric acids were used for all metal analyses.
All protocols were approved by the Institutional Review Board of the University of Chicago, and each study subject provided written consent prior to participation.
Kinetic study protocol. In a subset of four female smokers, it was determined whether cigarettes smoked just before or during a blood draw might increase the cadmium concentration measured in the circulation of smokers. For this evaluation, we analyzed both whole blood and the serum/plasma compartment. The latter compartment was important because nearly all of the cadmium in blood is bound to red blood cells and retained there with a 2-to 3-month half-life (Järup et al., 1983; Nordberg, 1984; Welinder et al., 1977) , but the serum/plasma compartment is very low in cadmium concentration and has not been analyzed by many investigators.
The four female smokers each provided five sequential blood samples: at 0 time and at 5, 15, 20, and 35 min. Each time blood was drawn, additional tubes were drawn for plasma or serum. Particular care was taken to avoid lysis of red blood cells during drawing and handling the blood samples because red blood cell lysis might inadvertently increase cadmium concentrations in the plasma/serum compartment (P-Cd) due to release of the large fraction of whole-blood cadmium that is bound to the red blood cells to this compartment. Several observations indicate that red blood cell lysis did not affect our P-Cd values. In almost all cases, the serum and plasma samples had a tawny color, indicating that little or no lysis of red blood cells had occurred. Furthermore, some lysis was observed that caused a small but steady increase in rose color with successive plasma samples that were taken from the nonsmoker who smoked two cigarettes; however, P-Cd values for these successive samples stayed the same or decreased (see Results).
Each subject smoked two cigarettes, one cigarette during the 5-min draw and one during the 15-min draw. For the latter draws, blood was drawn during the smoking process itself because small amounts of cadmium have been shown to clear very quickly (within minutes) to liver and kidney after entering the blood (Jonah and Bhattacharyya, 1989) . The time-points up to 20 min after the last cigarette were chosen to help guide our blood sampling protocol regarding recent smoking, i.e., if smoking were not restricted prior to blood sampling, subjects could reasonably have been expected to smoke within 5-20 min of the blood draw; results would determine whether that mattered, particularly regarding P-Cd values. One-milliliter aliquots of blood and ~3-ml aliquots of serum/plasma were analyzed. All steps were conducted in such a way to avoid cadmium contamination-skin at the draw site was carefully cleaned, the phlebotomist wore gloves, all sample transfers for cadmium analyses were conducted inside a biosafety cabinet.
Cadmium in diet.
For the four smokers in the kinetic study, at the time of the above blood draws, we also obtained duplicate samples of each food item and beverage that they had consumed on that day. The aim was to obtain detailed insight into cadmium intake via diet versus cigarettes for these four subjects, from morning waking to the time of their blood draw. Because blood was drawn in the afternoon, the diet sampling included breakfast and lunch. Again, this protocol provided insight into the plasma/serum compartment, where cadmium concentrations as they may be associated with dietary or inhalation exposures at environmental levels are not well known.
Each sample of solid food was weighed and placed in an acid-washed beaker, covered, dried in an oven overnight (100°C), and ashed in a muffle furnace (527°C for 48 h), and the ash was dissolved in 1N HNO 3 prior to cadmium analysis by graphite furnace atomic absorption spectrometry (GF-AAS) (SpectrAA 110/220, Varian, Inc.). Sulfuric acid was added to each sample before the overnight drying step to decrease cadmium volatilization during ashing (Peterson et al., 1991) . The mean cadmium recovery with this protocol was 82% using beakers, and duplicate diet samples spiked with known amounts of cadmium, indicating some cadmium loss during ashing. This recovery value was applied to calculations of cadmium amounts in samples. For all beverages, and for each solid food sample whose acid digest had a high background value and low cadmium signal upon direct analysis by GF-AAS, the original sample digest was reanalyzed for cadmium using the more sensitive assay, which concentrates the cadmium while dramatically reducing the background signal (Cerny and Bhattacharyya, 2003) .
Cadmium in inhaled mainstream cigarette smoke. The cigarettes obtained from the study participants, along with the Marlboro Ultralights used for quality control, were smoked individually on a smoking machine (LM1, Borgwaldt KC, Inc.). A quartz microfiber filter (QM-A, Whatman) set in a filter cassette was used (11) 62 ± 2 182 ± 17 30.9 ± 2.9 11 ± 2 Male smokers (5) 63 ± 5 174 ± 12 25.1 ± 1.5 NA Male nonsmokers (5) 61 ± 3 165 ± 6 25.9 ± 1.8 NA Note. NA, not applicable. a Values are mean ± SE for subject number shown in parentheses in first column. For each parameter and gender, smoker means are not significantly different from nonsmoker means (p > 0.05, two-sample t-test).
CADMIUM IN SMOKERS
to collect the total particulate matter (TPM) of mainstream smoke. The smoking protocol used a 2-sec puff duration, 35-ml puff volume, puff frequency of three times per minute, and 23-mm butt length. This protocol followed the FTC regimen for cigarette testing (NIH/NCI, 1996; Torrence et al., 2002) , except for puff frequency. Three puffs per minute were used because this rate simulated the frequency of our smokers better than the testing standard of one puff per minute. All cigarettes were equilibrated to 60% humidity for at least 24 h before analyzing on the smoking machine, according to the FTC regimen.
The amount of TPM in the inhaled mainstream smoke collected on the filter was determined by subtracting the weight of the filter cassette + filter taken before smoking from its weight after the cigarette was smoked, generating a value of milligram of TPM per cigarette. The cadmium content of the TPM was determined by extracting the cadmium from each quartz filter in a Teflon-capped 15-ml polyethylene centrifuge tube containing 14 ml 1N HNO 3 . Each tube was allowed to extract overnight and rotated for at least 2 h on a Roto-Shake Genie (Scientific Industries), and the extract was analyzed for cadmium by GF-AAS (SpectrAA 110/220, Varian, Inc.).
To validate the above extraction method for cadmium analysis of the quartz filters, eight Marlboro Ultralight cigarettes, all from the same pack, were individually smoked on the smoking machine with the smoking regimen described above. The resulting quartz filters were each analyzed for cadmium content, some by the acid extraction method described above and some by the furnace ashing method described for cadmium in diet. The acid extraction method gave the same results as the furnace ashing method for cadmium in inhaled mainstream TPM for the eight Marlboro Ultralight cigarettes smoked (mean ± SE, for [n] cigarettes): 19.9 ± 0.9 ng Cd/cigarette (3) versus 20.2 ± 1.2 ng Cd/cigarette (5), respectively. This close agreement gave confidence that the extraction method used to determine TPM cadmium content was reliable.
Analyses of Marlboro Ultralight Cigarettes
Reproducibility of cigarette characteristics. Marlboro Ultralight cigarettes were included in each smoking machine run of subjects' cigarettes, spacing them evenly among the test cigarettes (4 quality-control cigarettes per run, 8 runs; 20 Marlboro Ultralight cigarettes from one pack, 12 from second pack). The following five standard characteristics of these Marlboro Ultralights were determined to evaluate reproducibility of smoking machine measurements throughout the period of the smoking machine runs: (A) number of puffs per cigarette, (B) amount of TPM per cigarette in inhaled mainstream smoke (i.e., TPM on quartz filter) (mg TPM/cigarette), (C) amount of cadmium per cigarette in inhaled mainstream smoke TPM (i.e., Cd on quartz filter) (ng Cd/ cigarette), (D) amount of cadmium per puff (C ÷ A) (ng Cd/puff), and (E) concentration of cadmium in TPM (3 ÷ 2) (ng Cd/mg TPM).
Cadmium distribution among components of unsmoked and smoked cigarettes. To further characterize the Marlboro Ultralight cigarettes used for quality control, cadmium was determined in the unsmoked tobacco of three Marlboro Ultralight cigarettes (butts removed), and in the ash collected in the collection tray when three cigarettes from the same pack were individually smoked on the smoking machine. The tobacco and ash samples were analyzed using the protocol described for analysis of diet samples.
Cadmium Analyses in Whole Blood, Serum/Plasma, and Urine
Stored samples were analyzed for cadmium using the assay of Cerny and Bhattacharyya (2003) . This assay binds cadmium in 2N HCl to an anion exchange resin, washes the resin to remove non-Cd cations, and releases nearly salt-free Cd into 100 µl 1N HNO 3 for analysis by GF-AAS. In addition to minimizing matrix, this protocol concentrates cadmium originally present in 1 ml blood ~7-fold and in 3 ml plasma ~20-fold. U-Cd concentrations of each subject were adjusted to a specific gravity value of 1.020 to account for differences in osmolarity (Suwazono et al., 2005) .
Quality-Control Analyses of Blood, Serum/Plasma, and Urine
During each assay run, aliquots from pooled samples of blood, plasma, or urine were analyzed, with and without standard addition, to determine recovery and track reproducibility. Intra-and interassay coefficient of variations for the pooled samples (4-9 replicates) were 4.2 and 4.6%, respectively, for two pooled blood samples (mean B-Cd: 0.31 ng Cd/ml; 0.35 ng Cd/ml); 27 and 23%, respectively, for two pooled serum samples (mean S-Cd: 0.043 ng Cd/ml; 0.047 ng Cd/ml); and 4.8 and 9.8%, respectively, for two pooled urine samples (mean U-Cd: 0.44 ng Cd/ml; 0.32 ng Cd/ml). There was no difference in the mean cadmium concentration (± SE) for serum (0.037 ± 0.008 ng Cd/ml) versus plasma (0.039 ± 0.003 ng Cd/ml) for the six blood draws from which both types of sample were prepared. The detection limit, defined as 3 × SD of blank values (Torrence et al., 2002) , was 0.011 ng Cd/ml for whole blood, 0.007 ng Cd/ml for serum/plasma, and 0.018 ng Cd/ml for urine. Our cadmium concentrations for standard samples of blood (mean ± SD, n = 6) were 0.88 ± 0.13 ng Cd/ml compared with 1.1 and 1.2 ng Cd/ml for Canadian Blood Standards C-01-10 and C-01-15. Our concentrations for standard samples of urine (mean ± SD, n = 6) were 0.59 ± 0.07 ng Cd/ml compared with 0.67 ng Cd/ml for Canadian Urine Standards D-01-13 and D-01-16. Our values for cadmium in serum of our subjects (mean ± SD, n = 2) were 0.022 ± 0.004 ng Cd/ml, lowest value, 0.066 ± 0.003 ng Cd/ml, highest value, and 0.040 ng Cd/ml, mean for all samples. Our latter values for cadmium in serum were well within range of the certified value of 0.047 ± 0.004 ng Cd/g reported for animal serum SRM 1598a by NIST USA (Murphy et al., 2007) ; the latter value was obtained using a chromatographic separation procedure, as ours does, to dramatically decrease matrix interference. The above results gave us confidence that the methods used to analyze blood, serum, plasma, and urine were reliable.
Lead in Whole Blood
Cigarette tobacco contains similar amounts of both cadmium and lead (Galazyn-Sidorczuk et al., 2008) . Therefore, select blood samples were analyzed for both cadmium and lead to determine if levels of both these toxic metals were increased in the blood of smokers versus nonsmokers, or whether the increase was specific to cadmium. For lead analyses, blood samples were diluted 1:4 with 1N HNO 3 , vortexed for 30 s, let stand for 10 min, and centrifuged for 10 min at 1300 × g. The supernatant was analyzed for lead by GF-AAS with deuterium background correction, according to the method of Stoeppler et al. (1978) .
Statistical Analyses SAS 9.3 (SAS Institute, Cary, NC) was used for all statistical analyses. An alpha level of 0.05 was used to assess statistical significance. Descriptive statistics were calculated for all variables. The distributions for B-Cd and U-Cd were positively skewed, so a log transformation was used prior to analysis. Differences between smokers and nonsmokers were analyzed using a two-sample t-test. Simple linear regression was used to examine the relationship between U-Cd and B-Cd, as well as the relationship between I-Cd and B-Cd. A mixed-model repeated measures ANOVA was used to assess the intraclass correlation among I-Cd and B-Cd concentrations over 3 months.
RESULTS

Analyses of Marlboro Ultralight Cigarettes
Reproducibility of cigarette characteristics. The five standard characteristics of the Marlboro Ultralights showed little variation over eight smoking machine runs (mean ± SE, n = 8 runs): (A) 16.6 ± 0.2 puffs/cigarette, (B) 11.8 ± 0.7 mg TPM/cigarette in inhaled mainstream smoke, (C) 17.6 ± 0.6 ng Cd/cigarette in inhaled mainstream smoke TPM, and (D) 1.07 ± 0.04 ng Cd/puff (C ÷ A), 1.66 ± 0.14 ng Cd/mg TPM (C ÷ B). The relative standard errors for these interrun means were small, 1.2-8.4%, giving a strong basis to interpret differences between brands smoked by our subjects, even when those brands were analyzed in different runs on the smoking machine.
Cadmium distribution among components of unsmoked and smoked cigarettes. The unsmoked tobacco of the Marlboro Ultralights contained 628 ± 36 ng Cd/cigarette (mean ± SE, n = 3 cigarettes), and the ash collected in the tray after three additional cigarettes from the same pack had been smoked in the machine contained 93 ± 1 ng Cd/cigarette. Consequently, 85% of the tobacco cadmium, when the cigarette was smoked, was either retained in the butt (expected to be minor based on Galazyn-Sidorczuk et al., 2008) or released in mainstream and sidestream smoke.
Analyses of Cigarettes Smoked by Study Subjects
A conservative estimate of the cadmium content of inhaled mainstream smoke TPM, evaluated using the smoking machine and an FTC-based smoking regimen, ranged from 8.1 ng Cd/cigarette (True R) to 32.5 ng Cd/cigarette (Pall Mall NF) for the cigarettes smoked by our study participants (Table 2 ). Based on the findings of Hammond et al. (2006 Hammond et al. ( , 2007 on smoking topography observed for smokers of the lower tar-and nicotine-yield cigarettes available in recent years, the actual cadmium intake per cigarette was probably significantly higher. These Cd/cigarette values were highly consistent for cigarettes purchased by a given smoker over 2 months, a result confirmed by an intraclass correlation of 0.90. In addition, the amount of cadmium estimated to be inhaled per day by the female subjects (I-Cd) showed a 10-fold range from the lowest to highest value (71-706 ng Cd/day) ( Table 2) . I-Cd values were similar for male and female smokers, although the range of I-Cd values was narrower among male smokers (103-325 ng Cd/ day), possibly because the male group was smaller. Again, these I-Cd values, while reflective of the cigarettes that each During multiple home visits, subjects were observed to typically smoke reproducible fraction of cigarette, particularly noticeable for Subject 14. This fraction was recorded by each subject on cigarette diagram and included in estimate of inhaled Cd.
d Total Cd inhaled (Column 9) = (Column 8) × (Column 7) × (Column 6 mean). Meaning of "Total Cd inhaled" is amount breathed in by smoker via mainstream smoke, analogous to amount ingested via diet. It should be noted that the I-Cd values presented here, whereas reflective of the cigarettes that each subject smoked, underestimate the actual cadmium amounts inhaled by each subject, because the conservative FTC-based regimen that was used to program the smoking machine did not reflect the smoking topography observed for smokers of the lower tar and nicotine cigarettes present in today's market (Hammond et al., 2005 (Hammond et al., , 2006 (Hammond et al., , 2007 Jarvis et al., 2001) . (See Discussion for further insight and interpretation.) CADMIUM IN SMOKERS subject smoked, probably underestimated the actual cadmium amounts inhaled via mainstream smoke because of the FTC-based regimen used to program the smoking machine (Hammond et al., 2005 (Hammond et al., , 2006 (Hammond et al., , 2007 Jarvis et al., 2001) .
Estimates of Ingested Cadmium in Four Subjects
Cadmium concentrations varied among the diet groups, with grains showing the highest concentrations (e.g., sandwich, roll, goldfish crackers), and beverages and dairy products the lowest (Table 3 ). In addition, some supplements/ medicines had fairly high cadmium concentrations (Table 3 , pills), although their low weights meant they contributed little to daily cadmium intake. The total amount of cadmium in food for each of the four subjects was greater than their estimated intake via inhalation of mainstream cigarette smoke (2-to 20-fold greater), despite not sampling dinner, the biggest meal of the day for many.
Acute Effects of Smoking on Cadmium in Whole Blood and Serum/Plasma Compartment
Three important results emerged from this analysis. First, cadmium in whole blood was unaffected by smoking two cigarettes during a ~30-min sampling period (Fig. 1A) . They confirmed that we did not have to take into account recent smoking when scheduling draws for cadmium in whole blood. Second, cadmium concentrations in the serum/plasma compartment, which were extremely low as expected, showed no consistent rise or fall during a smoking session (Fig. 1B) . No rise in serum cadmium occurred even for a nonsmoker who smoked two Marlboro Regular cigarettes. That is, for Subject (Table 4) , serum cadmium concentrations (ng Cd/ml serum, mean ± SE, for replicate numbers shown in parentheses) were 0.036 ± 0.006 (5) before smoking, 0.038 ± 0.005 (2) during Cigarette 1 (at 5 min), and 0.024 ± 0.005 (2) during Cigarette 2 (at 15 min). Third, the concentration of cadmium in the serum/ plasma compartment did not reflect the concentration in whole blood. For example, B-Cd concentrations differed substantially among the participants (Fig. 1A) , whereas the differences among P-Cd concentrations were small (Fig. 1B) . In addition, for Smoker 10, cadmium was highest in blood but lowest in plasma, whereas for Smoker 12, cadmium concentrations for both compartments were comparatively high (Figs. 1A and B) .
B-Cd Concentrations in Smokers Versus Nonsmokers
Female smokers had a mean B-Cd of 1.21 ng Cd/ml, with a nearly 10-fold range from the lowest to highest value (0.29−2.74); nonsmokers had a significantly lower mean, 0.35 ng Cd/ml (p < 0.05), and narrower range of low to high value (0.20-0.61) ( Table 4 ). Means and ranges for males were similar (Table 5) . For both smokers and nonsmokers, B-Cd concentrations for FIG. 1. Effect of current smoking on cadmium in whole blood (A) and serum or plasma (B) of individual postmenopausal females. Each subject smoked two cigarettes, one at each arrow. Mean RSEs were 8% for blood and 29% for serum and plasma (samples run in duplicate). Calculations for serum and plasma include subtraction of blank for water drawn through needle into vacutainer tube (0.009 ± 0.002 ng Cd/ml), with propagation of error. Note that samples were taken for serum/plasma but not whole blood for Subject 14 at 5 min and Subject 2 at 20 min, explaining the two missing whole blood datapoints. a Values are ng Cd/ml blood, mean ± SE for n = 2 samples, unless n value indicated otherwise in parenthesis. Grand mean for smokers is higher than for nonsmokers (p < 0.05, two-sample t-test). (5) a Values are ng Cd/ml blood, mean ± SE for n = 2 samples, unless indicated otherwise in parenthesis. Grand mean for smokers is higher than for non-smokers (p < 0.05, two-sample t-test). each subject were highly consistent over 2 months (Tables 4 and  5) , as indicated by the intraclass correlation of 0.91.
Effects of Smoking on Blood Versus U-Cd Concentration: Comparison with Lead
The increase in cadmium concentration due to smoking was significant for both blood (Tables 4 and 5 ) and urine: smokers, 1.03 ± 0.09 ng Cd/ml urine (mean ± SE, n = 19) versus nonsmokers, 0.43 ± 0.04 ng Cd/ml (n = 9) (two-sample t-test, p < 0.05) (values adjusted to 1.020 specific gravity). In addition, the mean blood lead concentration for nonsmokers was low, 1.4 ± 0.2 µg Pb/dl blood (mean ± SE, n = 11), and, in contrast to cadmium, was not significantly increased among smokers (1.9 ± 0.2 µg Pb/dl blood, n = 19) (two-sample t-test, p > 0.05). These results confirm that the pathways responsible for increased B-Cd values in smokers are specific to the metal cadmium and not lead because both these metals are at similar concentrations in the original unsmoked cigarette tobacco (Galazyn-Sidorczuk et al., 2008) and in the original tobacco leaves (O'Connor et al., 2008; Torrence et al., 2002) .
B-Cd Versus I-Cd: Indication of Heterogeneity among Smokers
As shown in Figure 2A , 75% of the smokers (18/24, diamond data points) had B-Cd values that appeared to be directly related to the estimated amount of cadmium inhaled from cigarettes each day. In addition, this relationship appeared to intersect the y-axis at the B-Cd value of the nonsmokers (triangle), consistent with the nominal zero value for cadmium inhaled by nonsmokers. However, for the subset of persons with B-Cd concentrations above 1.5 ng Cd/ml, including both women and men (6/24, 25%, square data points), B-Cd concentrations were far higher for a given level of I-Cd, implying a potential heterogeneity within the smoker population.
B-Cd versus U-Cd: Further Indication of Heterogeneity
When we evaluated the association between B-Cd and U-Cd for each individual, two important findings emerged. First, among the smokers, there was no significant relationship between B-Cd and U-Cd (R 2 = 0.001, p = 0.92). Second, the group again appeared to be heterogeneous (Fig. 2B) , that is, the subset with blue diamond data points appeared to show a linear association between B-Cd and U-Cd that encompassed values of both smokers and nonsmokers and regressed through ~0,0. However, for persons with B-Cd concentrations above 1.5 ng/ ml (red square data points), the B-Cd concentrations were far higher for a given value of U-Cd.
Note that the study subjects represented by the red square data points in Figures 2A and 2B are the same persons, as identified by their common B-Cd values (shown beside each data point).
FIG. 2. Relationship of individual values of B-Cd to I-Cd (A) and B-Cd to U-Cd (B). Y-axis triangle in (A)
shows mean ± SE of B-Cd for non-smokers (n = 11), for whom I-Cd is nominally zero compared with smokers. Numerical values given for square datapoints show that high CdBs in (A) and (B) are from same subjects, except for subject with B-Cd of 2.74 in 2A, for whom U-Cd is missing. Note that a similar urine sample taken from this subject later in the study had a value of 0.40 ng Cd/ml, which would retain this subject's outlier status. Also note that a threefold increase in I-Cd values in 2A, to compensate for conservative FTC-based smoking regimen (see Discussion), would not change basic B-Cd to I-Cd relationship.
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DISCUSSION
Analyses of Cadmium in Inhaled Mainstream
Cigarette Smoke
The amount of cadmium in inhaled mainstream cigarette smoke TPM was determined using specific parameters for puff volume, puff duration, and puff frequency. This approach allowed us to compare cadmium in mainstream smoke for the multiple brands actually smoked by our study subjects. The TPM fraction was analyzed because nearly all of the cadmium in cigarette smoke is present in the particulate matter rather than in the vapor phase (Chang et al., 2003; Nitsch et al., 1991) . Quartz microfiber filters were used because they were suitably low in cadmium.
The cigarettes from the study subjects showed a range of 8-33 ng Cd/cigarette for cadmium in inhaled mainstream smoke TPM (Table 2 , Column 6). These values are in range of those reported by Counts et al. (2005) for cigarette brands obtained from multiple parts of the world, including the United States, when those investigators used the ISO smoking regimen most similar to ours (1.6-101 ng Cd/cigarette). Our values are lower, however, than cadmium amounts obtained by Counts et al. (2005) when more intense smoking regimens were used, such as the Massachusetts Department of Public Health (MPDH) and Health Canada (HC Intense) regimens. The latter regimen generated cadmium amounts in inhaled mainstream smoke TPM that were two-to threefold higher than the ISO regimen, when the cigarettes smoked had medium initial levels of filter ventilation (see Figs. 4 and 6, Counts et al., 2005) .
The technical reliability of our Cd/cigarette values (Table 2 , Column 6) is supported by the fact that (1) they are nearly the same as those of Pappas et al. (2006) for the two cigarette brands that we both analyzed: 17.2 versus 18.3 ng Cd/cigarette for Marlboro Ultralight and 23.5 versus 26.4 ng Cd/cigarette for Camel Light; and (2) Pappas et al. (2006) analyzed reference 1R4F cigarettes (University of Kentucky Reference Cigarette Program) and obtained a value (59.8 ± 2.8 ng Cd/cigarette), which is in good agreement with those reported by others for the 1R4F cigarettes (Counts et al., 2005; Torrence et al., 2002) . Therefore, although we did not obtain reference cigarettes from the University of Kentucky program (due to legal issues associated with transporting cigarettes across state lines to Argonne National Laboratory), our values for the reference cigarettes should have agreed with published results, based on our agreement with Pappas' values for the other two brands.
For a broader context, the highest value for cadmium content of inhaled mainstream smoke TPM reported by Pappas et al. for U.S. cigarettes is for Camel full-flavor menthol at 62.4 ng Cd/ cigarette (Pappas et al., 2006) , whereas amounts as high as 200-250 ng Cd/cigarette are reported for counterfeit cigarettes confiscated at U.S. borders (Pappas et al., 2007) . These results and ours indicate that estimates of added cadmium intake from smoking 20 cigarettes/day can show a very large range, depending on the type and source of cigarette, including counterfeit cigarettes (i.e., 8-250 ng Cd/cigarette × 20 cigarettes/day × 1 µg/1000 ng = 0.2-5 µg Cd/day).
Estimates of Cadmium Intake via Inhalation in Individual Subjects
A unique feature of this study is the fact that individual values of cadmium inhaled daily via mainstream cigarette smoke were estimated for each subject. Our results show that conservative estimates of I-Cd for persons in our study who smoked ≥ 20 cigarettes/day ranged from 0.2 to 0.7 µg Cd/day (Table 2, Values reported here are also consistent with other aspects reported by Galazyn-Sidorczuk et al. For example, the mean cadmium content of the unsmoked tobacco of our Marlboro Ultralight cigarettes was 0.63 µg Cd/cigarette, nearly identical to the mean for their cigarettes' unsmoked tobacco (0.62 µg Cd/cigarette) (Galazyn-Sidorczuk et al., 2008) . In addition, the mean value for cadmium in inhaled mainstream smoke TPM for our quality-control Marlboro Ultralights, 17.6 ng Cd/cigarette, represents 2.8% of the cadmium in the tobacco of those cigarettes, 0.63 µg Cd/cigarette. Based on the above agreements, the estimates reported here for cadmium intake via inhalation of mainstream cigarette smoke appear to be reasonable representations of our subjects' intake.
However, as indicated earlier in this report, a significant limitation to our estimates of I-Cd is the fact that the FTC-based smoking regimen that our study used produced lower I-Cd values than would have been obtained if a more intense smoking regimen had been used, a regimen that more closely reflected the smoking topography of humans smoking today's cigarettes. For example, the ISO/FTC regimen's total volume of inhaled mainstream smoke per cigarette was shown to be ~300 ml; in comparison, when smoking topography was measured individually in each subject (51 subjects) using a battery-operated portable device (CReSSmicro), 37-year-olds who smoked their regular brands or a very low-tar cigarette inhaled much larger volumes, ~600 or 800 ml/cigarette, respectively (Hammond et al., 2006) . Consequently, taking into account puff volume alone, I-Cd per cigarette determined by the ISO method should be increased two-to threefold to match the topography of 37-year-olds. The 60-year-olds in our study, however, would have had smaller respiratory volumes than the 37-year-olds (Degens et al., 2012) . Based on these considerations, one can reasonably estimate that each value of I-Cd in Table 2 (Column 9) may be systematically two-to threefold lower than actual values because of the smoking regimen used. This evaluation CADMIUM IN SMOKERS is consistent with data of Counts et al. (2005) , who showed a two-to threefold higher yield of cadmium in total inhaled mainstream smoke per cigarette, when the more intense smoking regimens of the MPDH and HC Intense were applied to cigarettes with medium initial levels of filter ventilation, rather than the ISO/FTC regimen (see Figs. 4 and 6, Counts et al., 2005) .
A second limitation to our values of I-Cd addresses individual variability. Although our I-Cd estimates took into account the particular brand each subject smoked, the number of cigarettes per day, and in a minor way, the personal habit of smoking a given length of the cigarette, only one smoking regimen was used to smoke all cigarettes. Our data set, therefore, assumed that smoking topography did not differ greatly among our elderly subjects. In reality, however, puff volume, puff duration, puff frequency, and the smoker's approach to covering the cigarette's filter vents (to prevent dilution of the cigarette smoke by air) will have varied among the individual smokers. By way of illustration, when subjects in the study of Hammond et al. (2006) smoked their own brand of cigarettes using the portable CreSSmicro device to measure individual smoking topography, the mean of total smoke volume per cigarette showed a relative standard deviation of 32% when the subjects smoked their usual brands, whereas ISO machine testing yielded a total smoke volume measurement with a much smaller relative standard deviation of 11%. An important result of this individual variability in smoking topography is illustrated in studies of nicotine intake. That is, persons who smoke cigarettes with a low nicotine yield (e.g., 0.1 mg) have been shown to smoke their cigarettes in such a way that they generate nearly the same range of saliva cotinine concentrations as persons who smoke cigarettes with a 10-fold higher nicotine yield (Jarvis et al., 2001) . To put this limitation in context, a percentage increase of 33-40% in inhaled volume per cigarette was demonstrated due to smoking low-tar cigarettes (Hammond et al., 2005, Fig. 2; Hammond et al., 2006) . These results indicate that the nine smokers in our study who smoked light or ultralight cigarettes (out of 24 smokers, Table 2 ) may have inhaled more deeply, puffed more frequently, or closed the filter vents (by squeezing the filter) more than did the other smokers, generating higher cadmium amounts in their inhaled mainstream smoke TPM relative to the other smokers.
Next, the argument can be made that the fraction of cigarette smoked, shown in Table 2 , is not highly useful because it will also vary over time for a given subject. Subject 14's clear habit of smoking only one-third of each cigarette triggered us to consider this parameter. As shown in Table 2 , fractions for all other subjects were 0.75-1.0, indicating that most subjects generally smoked their cigarettes close to or up to the filter, and, except for Subject 14, consideration of fraction smoked had little effect on our estimates of cadmium intake via inhalation.
Finally, consideration should be given to the sidestream smoke pathway. We report here that the cadmium in inhaled mainstream smoke for Marlboro Ultralight cigarettes (17.6 ng Cd/cigarette) accounted for only a small fraction (2.8%) of the cadmium present in the original tobacco (628 ng Cd/ cigarette) (see above). The additional 93 ng Cd/cigarette that we found deposited in the ash tray leaves 517 ng Cd/cigarette available for release via sidestream smoke or trapped in the cigarette's filter [628 − (18 + 93) = 517]. The sidestream smoke would contaminate the smokers' hands and clothes with cadmium-containing particulates, which could serve as an additional source of exposure. According to results in the literature, however, this secondary exposure source appears to be much smaller than direct inhalation of mainstream smoke, in that children residing in smoker households had the same mean B-Cd concentration as did children in smoker households, for a German population that had B-Cd values similar to those in our study (B-Cd means: 0.30 ng Cd/ml, children in nonsmoker household; 0.27 ng Cd/ml, children in smoker household) (Link et al., 2007) . Based on the above, for the study reported here, cadmium directly inhaled in mainstream smoke was used to estimate a smoker's exposure to cigarette smoke cadmium, and the mainstream smoke pathway was considered to reasonably reflect all smoking-related pathways.
Transfer of Cigarette Smoke Cadmium to Blood
The estimate of cadmium breathed in daily via mainstream smoke averaged 0.3 µg Cd/day for all subjects in Table 2 . As indicated earlier in this discussion, this value may better be estimated at 0.9 µg Cd/day (threefold higher) because of the conservative FTC-based regimen used for smoking the cigarettes of this study. The latter value is similar to values reported by others for daily cadmium intake due to smoking cigarettes and is still far less than estimations of daily intake from diet, reported to be ~15 µg Cd/day for U.S. and Swedish diets (Amzal et al., 2009; MacIntosh et al., 1996; Vanderpool and Reeves, 2001) . The individually paired data on inhaled versus ingested cadmium in Table 3 led us to further evaluate these cadmium intake pathways. For example, even if I-Cd were absorbed at 40% and ingested cadmium at 5%, absorption values typical of those reported in the literature (Flanagan et al., 1978; Järup and Akesson, 2009; Nordberg and Kjellstrom, 1979; Satarug et al., 2004; Vanderpool and Reeves, 2001) , the 3.5-fold higher B-Cd concentrations in smokers in our study could not be accounted for. That is, the average amount of cadmium reaching blood from the GI tract, 0.75 µg Cd/day (15 µg × 0.05), would still be twice that reaching blood from the lungs of our smokers, 0.36 µg Cd/day (0.9 µg × 0.40). This same conclusion is reached if we apply coefficients from the more detailed cadmium model of Nordberg and Kjellstrom to calculate cadmium transfer from lungs and GI tract to blood (Nordberg and Kjellstrom, 1979) , i.e., cadmium transferred from lungs to blood due to smoking would be 18 ng Cd/d, and that transferred from GI tract to blood from daily food consumption would be 38 ng Cd/d (Fig. 3) . The much lower amounts entering blood using this model can be traced to the fact that, in the Nordberg/Kjellstrom model, a significant fraction of cadmium taken in via the GI tract or
lungs is retained there, with only a small fraction transferred to blood. The latter model was chosen because it effectively models cadmium inhaled from cigarette smoke, replicating the twofold increase in kidney cadmium concentration observed in long-term smokers.
The above calculations indicate that aspects other than daily cadmium intake may need to be taken into account to explain the 3.5-fold increase in B-Cd concentration in our smokers. Although investigators report models for cadmium intake from diet, e.g., Amzal et al. (2009) , no recent model addresses cadmium inhaled via cigarette smoke, in spite of the fact that cigarette smoking is a significant source of cadmium exposure worldwide.
One possible explanation for why B-Cd concentrations are elevated in smokers is that cadmium may accumulate over time in the lungs of smokers to the point that the total lung pool delivers several times more cadmium to blood per day than the amount delivered daily from inhaled mainstream smoke. With this consideration, cadmium amounts coming from the lungs of smokers could eventually reach two times the amounts coming from the GI tract, supporting a tripling of B-Cd in smokers versus nonsmokers. Note that a build-up of cadmium in GI tract cells is also likely, as in the Nordberg/Kjellstrom model, but this build-up would be limited by the regular sloughing of these cells into feces. Increased cadmium accumulation in the lungs of smokers is supported by median lung cadmium concentrations that are threefold higher in smokers than in nonsmokers: 0.75 versus 0.18 µg Cd/g lung dry weight, respectively, with a greater absolute concentration range among smokers than among nonsmokers: 0.23-1.30 versus 0.06-0.22 µg/g lung dry weight, respectively (DePalma et al., 2008) .
With this explanation, one would predict that smokers would show no rise in B-Cd right after starting to smoke for the first time and that the B-Cd value in a particular smoker would reflect both the size of his/her lung cadmium pool and the biochemical nature of that pool regarding the rate of cadmium release to blood (see discussion below). Note that a lag in B-Cd rise after the start of exposure is reported for industrial workers whose main route of exposure is via inhalation (Lauwerys et al., 1979) .
Another possible explanation that should be considered is that cadmium reaching the blood from the GI tract may undergo enough presystemic sequestration by the liver via the portal vein that the daily contribution of GI-absorbed cadmium to the systemic circulation is significantly reduced. This explanation would make lung-derived cadmium a greater contributor to B-Cd than GI-derived cadmium, increasing the effects of smoking on B-Cd. This possibility is made less likely by results of Thompson and Klaassen (1983) , who demonstrate that the area under the blood concentration vs time curve after portal administration of cadmium to the rat (via the ileocolic vein) is not less than that following systemic administration (via the femoral vein).
The hypothesis remains that the higher B-Cd concentrations in smokers may be tied to a greater accumulation over time of cadmium in the lungs of smokers versus nonsmokers.
Increased Risk in a Subset?
In addition to providing clues regarding the basis for high B-Cds in smokers, our results raise the possibility that the smoker population may be heterogeneous, with a subset of smokers at increased risk of toxic effects at a given level of I-Cd (Fig. 2) . These results support the findings of many other investigators who show large ranges in B-Cd values in smokers (Batariova et al., 2006; Galazyn-Sidorczuk et al., 2008; Mijal and Holzman, 2010; Peters et al., 2010) . For example, in the study of Galazyn-Sidorczuk et al. (2008) , B-Cd concentrations among smokers ranged from 0.2 to 4.2 ng Cd/ml blood, even though I-Cd levels could not have differed by that much. That is, all subjects smoked ≥ 20 cigarettes/day for at least 10 years, and the cadmium concentrations, which were determined in that study from the tobacco of the subjects' cigarettes, varied little among the brands. Population heterogeneity might help explain the large range of B-Cd values and the finding of no significant relationship between pack-years smoked and B-Cd (Galazyn-Sidorczuk et al., 2008) .
Regarding a potential biochemical basis for heterogeneity in the B-Cd values, we know that lung cells synthesize MT in response to I-Cd and that this metal-binding protein avidly binds cadmium, protecting cells from its adverse effects (Hart et al., 2001; McKenna et al., 1998; Oberdorster et al., 1994) . Among mice that inhale cadmium, some strains synthesize much more MT in their lungs than others, both at baseline and after cadmium inhalation (McKenna et al., 1998) . If this heterogeneity also exists among humans, persons with lower MT expression might show increased transfer of non-MT-bound cadmium from lungs to blood.
Alternatively, the smokers with high B-Cd concentrations may have large cadmium pools built up in their lung cells. Recently, the zinc/bicarbonate symporter, ZIP, was shown to transport cadmium into cells via the apical membrane, with high ZIP expression corresponding to high cadmium uptake by kidney and prostate cells (He et al., 2009) . Heterogeneity may exist in levels of ZIP8, the ZIP isoform expressed in lungs   FIG. 3 . Transfer of inhaled and ingested cadmium to blood using coefficients from Nordberg-Kjellstrom model (1979) . About 0.9 µg Cd/day is average of estimated amount of cadmium inhaled per day via mainstream smoke TPM for smokers in our study (0.3 µg Cd/day, Table 2 , Column 9 average), increased threefold to account for conservative nature of FTC-based smoking machine regimen used (see Discussion). About 15 µg Cd/day is estimated amount of cadmium consumed per day via diet, based on U.S. and Swedish diets (Amzal et al., 2009; MacIntosh et al., 1996; Vanderpool and Reeves, 2001 ). (He et al., 2009) , resulting in heterogeneity in lung cell uptake of cadmium. Such heterogeneity might help explain the large range of cadmium concentrations for the lungs of smokers reported by DePalma et al. (2008) .
Finally, although biochemical pathways for lung to blood transfer of cadmium have not been extensively studied, tight junctions between alveolar epithelial cells appear to play a role (Papritz et al., 2010) . If tight junctions were more readily damaged by smoking in some individuals, cadmium could move from lung to blood at a greater rate in those individuals.
We have so far considered lung differences among smokers as a basis for potential heterogeneity because the lungs are the first organ that inhaled cigarette smoke encounters. However, cadmium from the GI tract is rapidly and extensively taken up by the liver Jonah and Bhattacharyya, 1989) . As another possibility, the livers of smokers, if damaged, might extract less cadmium from blood, indirectly raising B-Cd concentrations in smokers versus nonsmokers; differences in liver injury among smokers could contribute to their B-Cd heterogeneity. Finally, the older age of our study population may increase the severity of smoking effects on organs and the diversity of those effects on cadmium pathways. This interpretation is consistent with the clearly greater incidence of high B-Cd concentrations termed "outliers" and "extremes" reported by Nordberg et al. (2000) in smokers with a mean age of 87 years than in nonsmokers in that same age group.
Other Study Limitations
We present a highly detailed study of cadmium exposures in a relatively small number of smokers. Although our results point to heterogeneity within this group that seems to be corroborated by the large ranges of B-Cd among smokers reported by others, a follow-up study in a larger population is required to further test the hypothesis of B-Cd heterogeneity after cadmium inhalation exposure.
Among nonsmokers, iron status has been shown to be inversely related to U-Cd concentration (Akesson et al., 2002; Satarug et al., 2004) . We did not evaluate iron status in our subjects and therefore could not evaluate whether lower iron status in smokers might have contributed to their higher B-Cd values. A future study that includes serum ferritin levels could evaluate this additional parameter. In this case, low iron could potentially enhance cadmium pathways to blood from both the GI tract and lungs.
CONCLUSIONS
We conclude that the amount of cadmium estimated to be taken in daily by our smokers via mainstream smoke is insufficient to explain the high B-Cd concentrations in our smokers, pointing to differences in lung cadmium concentrations and pathways to blood from lungs. We also conclude that smokers with high blood-to-inhaled cadmium ratios may reflect a potentially important heterogeneity in the smoker population. Our results establish a rationale to further validate this heterogeneity and investigate its source.
